|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
||
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification Number)
|
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Registrant’s Area Code and Telephone Number)
|
|
Title of each class
|
Trading symbol
|
Name of exchange on which registered
|
||
|
|
Accelerated filer ☐
|
|
|
Non-accelerated filer ☐
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Short-term investments
|
|
|
||||||
|
Accounts receivable, net
|
|
|
||||||
|
Inventories:
|
||||||||
|
Finished goods
|
|
|
||||||
|
Work in process
|
|
|
||||||
|
Raw materials
|
|
|
||||||
|
Total inventories
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property and equipment, at cost:
|
||||||||
|
Land
|
|
|
||||||
|
Buildings and improvements
|
|
|
||||||
|
Machinery and equipment
|
|
|
||||||
|
Construction in progress
|
|
|
||||||
|
Allowance for depreciation
|
(
|
)
|
(
|
)
|
||||
|
Property and equipment, net
|
|
|
||||||
|
Right of use assets
|
|
|
||||||
| Deferred income taxes |
||||||||
|
Goodwill
|
|
|
||||||
|
Other intangible assets, net
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Liabilities and equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade accounts payable
|
$
|
|
$
|
|
||||
|
Payroll and related expenses
|
|
|
||||||
|
Lease liabilities
|
|
|
||||||
|
Other accrued expenses
|
|
|
||||||
|
Income taxes
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term debt less current portion
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Long-term lease liabilities
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
Accrued pension and other postretirement costs
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Stockholders' equity:
|
||||||||
|
Common stock
|
|
|
||||||
|
Class B convertible common stock
|
|
|
||||||
|
Capital in excess of par value
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive income
|
|
|
||||||
|
Total equity
|
|
|
||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Net revenues
|
$
|
|
$
|
|
||||
|
Costs of products sold
|
|
|
||||||
|
Gross profit
|
|
|
||||||
|
Selling, general, and administrative expenses
|
|
|
||||||
|
Operating income
|
|
|
||||||
|
Other income (expense):
|
||||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
||||
|
Other
|
|
|
||||||
|
Total other income (expense)
|
(
|
)
|
(
|
)
|
||||
|
Income (loss) before taxes
|
|
(
|
)
|
|||||
|
Income tax expense (benefit)
|
|
(
|
)
|
|||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Basic earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Diluted earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Weighted average shares outstanding - basic
|
|
|
||||||
|
Weighted average shares outstanding - diluted
|
|
|
||||||
|
Cash dividends per share
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Other comprehensive income (loss), net of tax
|
||||||||
|
Pension and other post-retirement actuarial items
|
|
|
||||||
|
Foreign currency translation adjustment
|
(
|
)
|
|
|||||
|
Other comprehensive income (loss)
|
(
|
)
|
|
|||||
|
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
|||
|
Three fiscal months ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Operating activities
|
||||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
(Gain) loss on disposal of property and equipment
|
(
|
)
|
|
|||||
|
Inventory write-offs for obsolescence
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
| Stock compensation expense |
||||||||
|
Other
|
(
|
)
|
(
|
)
|
||||
|
Net change in operating assets and liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Investing activities
|
||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from sale of property and equipment
|
|
|
||||||
| Purchase of short-term investments | ( |
) | ( |
) | ||||
|
Maturity of short-term investments
|
|
|
||||||
|
Other investing activities
|
|
(
|
)
|
|||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Financing activities
|
||||||||
|
Net proceeds from revolving credit facility
|
|
|
||||||
|
Dividends paid to common stockholders
|
(
|
)
|
(
|
)
|
||||
|
Dividends paid to Class B common stockholders
|
(
|
)
|
(
|
)
|
||||
|
Repurchase of common stock
|
( |
) | ||||||
|
Cash withholding taxes paid when shares withheld for vested equity awards
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
)
|
|
|||||
|
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
Common Stock
|
Class B Convertible Common Stock
|
Capital in Excess of Par Value
|
Retained Earnings
|
Treasury Stock |
Accumulated Other Comprehensive Income (Loss)
|
Total Equity
|
||||||||||||||||||||||
|
Balance at December 31, 2024
|
$
|
|
$
|
|
$
|
|
$
|
|
$ | ( |
) |
$
|
(
|
)
|
$
|
|
||||||||||||
|
Net earnings (loss)
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
||||||||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
|
( |
) |
|
|
(
|
)
|
|||||||||||||||||||||
|
Dividends declared ($
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
||||||||||||||||||||||||
| Repurchase of common stock held in treasury ( |
( |
) | ( |
) | ||||||||||||||||||||||||
|
Balance at March 29, 2025
|
$
|
|
$
|
|
$
|
|
$
|
|
$ | ( |
) |
$
|
(
|
)
|
$
|
|
||||||||||||
| Balance at December 31, 2025 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
Net earnings
|
||||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Dividends declared ($
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
|
|
||||||||||||||||||||||
| Balance at April 4, 2026 |
$
|
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
$
|
|
|||||||||||||||
| Expense recorded in 2024 |
$ | |||
| Utilized |
( |
) | ||
| Foreign currency translation |
( |
) | ||
| Balance at December 31, 2024 |
$ | |||
| Utilized |
(
|
)
|
||
| Foreign currency translation |
|
|||
| Balance at December 31, 2025 |
$
|
|
||
| Utilized |
( |
) | ||
| Foreign currency translation |
||||
| Balance at April 4, 2026 | $ |
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Credit facility
|
$
|
|
$
|
|
||||
| Convertible senior notes, due 2030 | ||||||||
|
Deferred financing costs
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Less current portion
|
|
|
||||||
|
$
|
|
$
|
|
|||||
| 2030 Notes | ||||
|
Issuance date
|
||||
|
Maturity date
|
||||
|
Principal amount as of April 4, 2026
|
$ | |||
|
Cash coupon rate (per annum)
|
% | |||
|
Conversion rate (per $1 principal amount)
|
||||
|
Effective conversion price (per share)
|
$ | |||
|
|
$ | |||
|
Fiscal quarters ended
|
|||||||
|
April 4, 2026
|
March 29, 2025 |
||||||
|
Dividends paid to stockholders
|
$ |
|
$ | ||||
|
Stock repurchases
|
|
||||||
|
Total
|
$ |
|
$ | ||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Beginning balance
|
$
|
|
$
|
|
||||
|
Sales allowances
|
|
|
||||||
|
Credits issued
|
(
|
)
|
(
|
)
|
||||
|
Foreign currency
|
(
|
)
|
|
|||||
|
Ending balance
|
$
|
|
$
|
|
||||
|
Pension and
other post-
retirement
actuarial
items
|
Currency
translation
adjustment
|
Total
|
||||||||||
|
Balance at January 1, 2026
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Tax effect
|
|
|
$
|
|
||||||||
|
Other comprehensive income (loss) before reclassifications, net of tax
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI
|
|
|
$
|
|
||||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI, net of tax
|
|
|
$
|
|
||||||||
|
Net other comprehensive income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Balance at April 4, 2026
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Fiscal quarter ended
April 4, 2026
|
Fiscal quarter ended
March 29, 2025
|
|||||||||||||||
|
U.S. Plans
|
Non-U.S.
Plans
|
U.S. Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Net service cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Expected return on plan assets
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Amortization of prior service cost
|
|
|
|
|
||||||||||||
|
Amortization of losses
|
|
|
|
|
||||||||||||
|
Curtailment and settlement losses
|
|
|
|
|
||||||||||||
|
Net periodic benefit cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Fiscal quarter ended
April 4, 2026
|
Fiscal quarter ended
March 29, 2025
|
|||||||||||||||
|
U.S. Plans
|
Non-U.S.
Plans
|
U.S. Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Service cost
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Amortization of losses (gains)
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Net periodic benefit cost
|
$ |
|
(
|
)
|
$ |
|
|
$ |
|
|
$ |
|
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Restricted stock units ("RSUs")
|
$
|
|
$
|
|
||||
|
Phantom stock units
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Unrecognized
Compensation
Cost
|
Weighted
Average
Remaining
Amortization
Periods
|
|||||||
|
Restricted stock units
|
$
|
|
|
|||||
|
Phantom stock units
|
|
n/a
|
||||||
|
Total
|
$
|
|
||||||
|
Number of
RSUs
|
Weighted
Average
Grant-date
Fair Value per
Unit
|
|||||||
|
Outstanding:
|
||||||||
|
January 1, 2026
|
|
$
|
|
|||||
|
Granted
|
|
|
||||||
|
Vested*
|
(
|
)
|
|
|||||
|
Cancelled or forfeited
|
(
|
)
|
|
|||||
|
Outstanding at April 4, 2026
|
|
$
|
|
|||||
|
Expected to vest at April 4, 2026
|
|
|||||||
|
Vesting Date
|
Expected
to Vest
|
Not Expected
to Vest
|
Total
|
|||||||||
|
January 1, 2027
|
||||||||||||
| January 1, 2028 |
||||||||||||
| January 1, 2029 |
|
|
|
|||||||||
|
March 1, 2029
|
||||||||||||
|
Number of
units
|
Grant-date
Fair Value per
Unit
|
|||||||
|
Outstanding:
|
||||||||
|
January 1, 2026
|
|
|||||||
|
Granted
|
|
$
|
|
|||||
|
Dividend equivalents issued
|
|
|||||||
|
Outstanding at April 4, 2026
|
|
|||||||
|
MOSFETs
|
Diodes
|
Optoelectronic
Components
|
Resistors
|
Inductors
|
Capacitors
|
Corporate/
Other
|
Total
|
|||||||||||||||||||||||||
|
Fiscal quarter ended April 4, 2026:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||
| Cost of products sold (excluding depreciation) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Depreciation expense in costs of products sold |
||||||||||||||||||||||||||||||||
| Total costs of products sold |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Gross profit |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating expenses |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating income |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Total depreciation expense |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Capital expenditures |
||||||||||||||||||||||||||||||||
| Total assets as of April 4, 2026: |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
Fiscal quarter ended March 29, 2025:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||
| Cost of products sold (excluding depreciation) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Depreciation expense in cost of products sold |
||||||||||||||||||||||||||||||||
| Total cost of products sold |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Gross profit |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating expenses |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating income (loss) |
$ | ( |
) | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
| Total depreciation expense |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Capital expenditures |
||||||||||||||||||||||||||||||||
|
Total assets as of March 29, 2025:
|
$
|
|
$
|
|
$ | $ | $ | $ | $ |
$
|
|
|||||||||||||||||||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Reconciliation:
|
||||||||
|
Segment Operating Income
|
$
|
|
$
|
|
||||
|
Unallocated Selling, General, and Administrative Expenses
|
(
|
)
|
(
|
)
|
||||
|
Consolidated Operating Income
|
$
|
|
$
|
|
||||
|
Unallocated Other Income (Expense)
|
(
|
)
|
(
|
)
|
||||
|
Consolidated Income (Loss) Before Taxes
|
$
|
|
$
|
(
|
)
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Distributors
|
$
|
|
$
|
|
||||
|
OEMs
|
|
|
||||||
|
EMS companies
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Asia
|
$
|
|
$
|
|
||||
|
Europe
|
|
|
||||||
|
Americas
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
| Fiscal quarters ended |
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Industrial
|
$
|
|
$
|
|
||||
|
Automotive
|
|
|
||||||
|
Military and Aerospace
|
|
|
||||||
|
Healthcare
|
|
|
||||||
|
Other*
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Numerator:
|
||||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Denominator:
|
||||||||
|
Denominator for basic earnings (loss) per share:
|
||||||||
|
Weighted average shares
|
|
|
||||||
|
Outstanding phantom stock units
|
|
|
||||||
|
Adjusted weighted average shares - basic
|
|
|
||||||
|
Effect of dilutive securities:
|
||||||||
|
Restricted stock units
|
|
|
||||||
|
Dilutive potential common shares
|
|
|
||||||
|
Denominator for diluted earnings (loss) per share:
|
||||||||
|
Adjusted weighted average shares - diluted
|
|
|
||||||
|
Basic earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Diluted earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Restricted stock units
|
|
|
||||||
|
Total
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
| April 4, 2026 |
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
$
|
$
|
$
|
||||||||||||
|
Available for sale securities
|
$
|
|||||||||||||||
|
$
|
$
|
$
|
$
|
|||||||||||||
| Liability: |
||||||||||||||||
| Acquisitions contingent consideration |
$ | $ | $ | $ | ||||||||||||
| December 31, 2025
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
$
|
$
|
$
|
||||||||||||
|
Available for sale securities
|
$
|
|||||||||||||||
|
$
|
$
|
$
|
$
|
|||||||||||||
| Liability: |
||||||||||||||||
| Acquisitions contingent consideration |
$ | $ | $ | $ | ||||||||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net cash provided by continuing operating activities
|
$
|
63,669
|
$
|
149,362
|
$
|
16,098
|
||||||
|
Proceeds from sale of property and equipment
|
66
|
308
|
279
|
|||||||||
|
Less: Capital expenditures
|
(110,661
|
)
|
(94,802
|
)
|
(61,569
|
)
|
||||||
|
Free cash
|
$
|
(46,926
|
)
|
$
|
54,868
|
$
|
(45,192
|
)
|
||||
| Fiscal quarters ended |
||||||||
|
April 4, 2026
|
March 29, 2025 |
|||||||
|
Dividends paid to stockholders
|
$ |
|
13,611
|
$ | 13,562 | |||
|
Stock repurchases
|
-
|
12,538 | ||||||
|
Total
|
$ |
|
13,611
|
$ | 26,100 | |||
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
Net revenues
|
$
|
715,236
|
$
|
762,250
|
$
|
790,640
|
$
|
800,922
|
$
|
839,242
|
||||||||||
|
Gross profit margin
|
19.0
|
%
|
19.5
|
%
|
19.5
|
%
|
19.6
|
%
|
21.0
|
%
|
||||||||||
|
Operating margin(1)
|
0.1
|
%
|
2.9
|
%
|
2.4
|
%
|
1.8
|
%
|
2.6
|
%
|
||||||||||
|
End-of-period backlog
|
$
|
1,124,300
|
$
|
1,174,900
|
$
|
1,152,700
|
$
|
1,314,100
|
$
|
1,592,300
|
||||||||||
|
Book-to-bill ratio
|
1.08
|
1.02
|
0.97
|
1.20
|
1.34
|
|||||||||||||||
|
Inventory turnover
|
3.3
|
3.3
|
3.3
|
3.4
|
3.4
|
|||||||||||||||
|
Change in ASP vs. prior quarter
|
(1.3
|
)%
|
0.0
|
%
|
(0.3
|
)%
|
(0.3
|
)%
|
(1.1
|
)%
|
||||||||||
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
MOSFETs
|
||||||||||||||||||||
|
Net revenues
|
$
|
142,113
|
$
|
148,633
|
$
|
167,133
|
$
|
172,584
|
$
|
173,991
|
||||||||||
|
Book-to-bill ratio
|
1.32
|
1.00
|
0.86
|
1.48
|
1.57
|
|||||||||||||||
|
Gross profit margin
|
8.2
|
%
|
6.3
|
%
|
10.1
|
%
|
13.8
|
%
|
12.9
|
%
|
||||||||||
|
Segment operating margin
|
(6.1
|
)%
|
(9.7
|
)%
|
(3.8
|
)%
|
(0.5
|
)%
|
0.8
|
%
|
||||||||||
|
Diodes
|
||||||||||||||||||||
|
Net revenues
|
$
|
140,963
|
$
|
147,942
|
$
|
149,628
|
$
|
154,224
|
$
|
163,669
|
||||||||||
|
Book-to-bill ratio
|
0.99
|
0.93
|
1.07
|
1.09
|
1.35
|
|||||||||||||||
|
Gross profit margin
|
19.9
|
%
|
20.0
|
%
|
20.3
|
%
|
20.3
|
%
|
21.3
|
%
|
||||||||||
|
Segment operating margin
|
15.0
|
%
|
15.0
|
%
|
15.2
|
%
|
15.3
|
%
|
15.8
|
%
|
||||||||||
|
Optoelectronic Components
|
||||||||||||||||||||
|
Net revenues
|
$
|
51,168
|
$
|
54,119
|
$
|
55,590
|
$
|
55,674
|
$
|
58,875
|
||||||||||
|
Book-to-bill ratio
|
0.90
|
1.05
|
0.93
|
1.12
|
1.48
|
|||||||||||||||
|
Gross profit margin
|
20.9
|
%
|
23.2
|
%
|
22.9
|
%
|
15.0
|
%
|
18.6
|
%
|
||||||||||
|
Segment operating margin
|
10.6
|
%
|
12.6
|
%
|
12.9
|
%
|
4.5
|
%
|
8.0
|
%
|
||||||||||
|
Resistors
|
||||||||||||||||||||
|
Net revenues
|
$
|
179,500
|
$
|
194,769
|
$
|
195,707
|
$
|
189,367
|
$
|
203,743
|
||||||||||
|
Book-to-bill ratio
|
1.00
|
0.91
|
0.92
|
1.05
|
1.26
|
|||||||||||||||
|
Gross profit margin
|
22.5
|
%
|
22.8
|
%
|
20.1
|
%
|
19.4
|
%
|
22.0
|
%
|
||||||||||
|
Segment operating margin
|
17.4
|
%
|
17.9
|
%
|
15.3
|
%
|
14.3
|
%
|
16.8
|
%
|
||||||||||
|
Inductors
|
||||||||||||||||||||
|
Net revenues
|
$
|
84,121
|
$
|
95,675
|
$
|
91,990
|
$
|
92,588
|
$
|
92,225
|
||||||||||
|
Book-to-bill ratio
|
1.02
|
0.91
|
0.99
|
1.07
|
1.31
|
|||||||||||||||
|
Gross profit margin
|
20.9
|
%
|
28.0
|
%
|
30.7
|
%
|
29.8
|
%
|
31.8
|
%
|
||||||||||
|
Segment operating margin
|
16.5
|
%
|
24.0
|
%
|
26.6
|
%
|
25.4
|
%
|
27.4
|
%
|
||||||||||
|
Capacitors
|
||||||||||||||||||||
|
Net revenues
|
$
|
117,371
|
$
|
121,112
|
$
|
130,592
|
$
|
136,485
|
$
|
146,739
|
||||||||||
|
Book-to-bill ratio
|
1.13
|
1.40
|
1.07
|
1.30
|
1.13
|
|||||||||||||||
|
Gross profit margin
|
23.2
|
%
|
21.5
|
%
|
20.1
|
%
|
21.3
|
%
|
23.4
|
%
|
||||||||||
|
Segment operating margin
|
17.5
|
%
|
16.3
|
%
|
15.2
|
%
|
16.6
|
%
|
18.7
|
%
|
||||||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Cost of products sold
|
79.0
|
%
|
80.4
|
%
|
81.0
|
%
|
||||||
|
Gross profit
|
21.0
|
%
|
19.6
|
%
|
19.0
|
%
|
||||||
|
Selling, general & administrative expenses
|
18.4
|
%
|
17.7
|
%
|
18.8
|
%
|
||||||
|
Operating income
|
2.6
|
%
|
1.8
|
%
|
0.1
|
%
|
||||||
|
Income (loss) before taxes
|
1.5
|
%
|
0.7
|
%
|
(0.6
|
)%
|
||||||
|
Net earnings (loss)
|
0.9
|
%
|
0.1
|
%
|
(0.6
|
)%
|
||||||
|
________
|
||||||||||||
|
Effective tax rate
|
44.3
|
%
|
82.3
|
%
|
3.2
|
%
|
||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
839,242
|
$ |
|
800,922
|
$ |
|
715,236
|
|||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
38,320
|
4.8
|
%
|
||||||
|
March 29, 2025
|
$ |
124,006
|
17.3
|
%
|
||||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
5.8
|
%
|
14.4
|
%
|
||||
|
Decrease in average selling prices
|
(1.1
|
)%
|
(0.8
|
)%
|
||||
|
Foreign currency effects
|
0.2
|
%
|
3.9
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.2
|
)%
|
||||
|
Net change
|
4.8
|
%
|
17.3
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$
|
173,991
|
$
|
172,584
|
$
|
142,113
|
||||||
| Gross profit margin |
12.9 | % | 13.8 | % | 8.2 | % | ||||||
|
Segment operating margin
|
0.8
|
%
|
(0.5
|
)%
|
(6.1
|
)%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
1,407
|
0.8
|
%
|
||||||
|
March 29, 2025
|
$ |
31,878
|
22.4
|
%
|
||||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
1.4
|
%
|
26.8
|
%
|
||||
|
Decrease in average selling prices
|
(0.8
|
)%
|
(5.2
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
2.3
|
%
|
||||
|
Other
|
0.1
|
%
|
(1.5
|
)%
|
||||
|
Net change
|
0.8
|
%
|
22.4
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
163,669
|
$ |
|
154,224
|
$ |
|
140,963
|
|||
| Gross profit margin |
21.3 | % | 20.3 | % | 19.9 | % | ||||||
|
Segment operating margin
|
15.8
|
%
|
15.3
|
%
|
15.0
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
9,445
|
6.1
|
%
|
|||||
|
March 29, 2025
|
$ |
|
22,706
|
16.1
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
8.4
|
%
|
14.4
|
%
|
||||
|
Decrease in average selling prices
|
(2.1
|
)%
|
(1.1
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
3.2
|
%
|
||||
|
Other
|
(0.3
|
)%
|
(0.4
|
)%
|
||||
|
Net change
|
6.1
|
%
|
16.1
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
58,875
|
$ |
|
55,674
|
$ |
|
51,168
|
|||
|
Gross profit margin
|
18.6
|
%
|
15.0
|
%
|
20.9
|
%
|
||||||
|
Segment operating margin
|
8.0
|
%
|
4.5
|
%
|
10.6
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
3,201
|
5.7
|
%
|
|||||
|
March 29, 2025
|
$ |
|
7,707
|
15.1
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
6.6
|
%
|
12.0
|
%
|
||||
|
Decrease in average selling prices
|
(1.1
|
)%
|
(2.1
|
)%
|
||||
|
Foreign currency effects
|
0.3
|
%
|
5.6
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.4
|
)%
|
||||
|
Net change
|
5.7
|
%
|
15.1
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
203,743
|
$ |
|
189,367
|
$ |
|
179,500
|
|||
| Gross profit margin |
22.0 | % | 19.4 | % | 22.5 | % | ||||||
|
Segment operating margin
|
16.8
|
%
|
14.3
|
%
|
17.4
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
14,376
|
7.6
|
%
|
|||||
|
March 29, 2025
|
$ |
|
24,243
|
13.5
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
7.7
|
%
|
6.5
|
%
|
||||
|
Change in average selling prices
|
(0.4
|
)%
|
2.2
|
%
|
||||
|
Foreign currency effects
|
0.2
|
%
|
4.6
|
%
|
||||
|
Other
|
0.1
|
%
|
0.2
|
%
|
||||
|
Net change
|
7.6
|
%
|
13.5
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
92,225
|
$ |
|
92,588
|
$ |
|
84,121
|
|||
| Gross profit margin |
31.8 | % | 29.8 | % | 20.9 | % | ||||||
|
Segment operating margin
|
27.4
|
%
|
25.4
|
%
|
16.5
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
(363
|
)
|
(0.4
|
)%
|
||||
|
March 29, 2025
|
$ |
|
8,104
|
9.6
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
2.2
|
%
|
9.0
|
%
|
||||
|
Decrease in average selling prices
|
(2.6
|
)%
|
(1.2
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
1.9
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.1
|
)%
|
||||
|
Net change
|
(0.4
|
)%
|
9.6
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
146,739
|
$ |
|
136,485
|
$ |
|
117,371
|
|||
| Gross profit margin |
23.4 | % | 21.3 | % | 23.2 | % | ||||||
|
Segment operating margin
|
18.7 | % | 16.6 | % | 17.5 | % | ||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
10,254
|
7.5
|
%
|
|||||
|
March 29, 2025
|
$ |
|
29,368
|
25.0
|
%
|
|||||
|
vs. Prior
Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
7.7
|
%
|
16.4
|
%
|
||||
|
Change in average selling prices
|
(0.2
|
)%
|
1.8
|
%
|
||||
|
Foreign currency effects
|
0.3
|
%
|
6.6
|
%
|
||||
|
Other
|
(0.3
|
)%
|
0.2
|
%
|
||||
|
Net change
|
7.5
|
%
|
25.0
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Total SG&A expenses
|
$ |
|
154,488
|
$ |
|
141,999
|
$ |
|
134,739
|
|||
|
as a percentage of revenues
|
18.4
|
%
|
17.7
|
%
|
18.8
|
%
|
||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
Change
|
||||||||||
|
Foreign exchange loss
|
$
|
(586
|
)
|
$
|
(506
|
)
|
$
|
(80
|
)
|
|||
|
Interest income
|
3,038
|
2,753
|
285
|
|||||||||
|
Other components of net periodic pension expense
|
(1,919
|
)
|
(2,442
|
)
|
523
|
|||||||
|
Investment income (expense)
|
170
|
(111
|
)
|
281
|
||||||||
|
Other
|
(2
|
)
|
843
|
(845
|
)
|
|||||||
|
$
|
701
|
$
|
537
|
$
|
164
|
|||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
March 29, 2025
|
Change
|
||||||||||
|
Foreign exchange gain (loss)
|
$
|
(586
|
)
|
$
|
1,329
|
$
|
(1,915
|
)
|
||||
|
Interest income
|
3,038
|
3,877
|
(839
|
)
|
||||||||
|
Other components of net period pension expense
|
(1,919
|
)
|
(1,697
|
)
|
(222
|
)
|
||||||
|
Investment income
|
170
|
261
|
(91
|
)
|
||||||||
|
Other
|
(2
|
)
|
(23
|
)
|
21
|
|||||||
|
$
|
701
|
$
|
3,747
|
$
|
(3,046
|
)
|
||||||
|
Fiscal quarters ended
|
||||||||||||||||||||
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
Days sales outstanding ("DSO") (a)
|
53
|
53
|
53
|
48
|
41
|
|||||||||||||||
|
Days inventory outstanding ("DIO") (b)
|
110
|
109
|
108
|
107
|
106
|
|||||||||||||||
|
Days payable outstanding ("DPO") (c)
|
(34
|
)
|
(32
|
)
|
(31
|
)
|
(30
|
)
|
(31
|
)
|
||||||||||
|
Cash conversion cycle
|
129
|
130
|
130
|
125
|
116
|
|||||||||||||||
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Credit facility
|
$
|
250,000
|
$
|
219,000
|
||||
|
Convertible senior notes, due 2030
|
750,000
|
750,000
|
||||||
|
Deferred financing costs
|
(16,910
|
)
|
(18,107
|
)
|
||||
|
Total debt
|
983,090 | 950,893 | ||||||
|
Cash and cash equivalents
|
479,357 | 514,966 | ||||||
|
Short-term investments
|
191 | 265 | ||||||
|
Net cash and short-term investments (debt)
|
$ | (503,542 | ) | (435,662 | ) | |||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 4. |
Controls and Procedures
|
| Item 1. |
Legal Proceedings
|
| Item 1A. |
Risk Factors
|
| Item 5. |
Other Information
|
| Item 6. |
Exhibits
|
|
101
|
Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended April 4, 2026, furnished in iXBRL (Inline eXtensible Business
Reporting Language)).
|
|
104
|
Cover Page Interactive Data File (formatted as Inline eXtensible Business Reporting Language and contained in Exhibit 101)
|
|
VISHAY INTERTECHNOLOGY, INC.
|
||
|
/s/ David E. McConnell
|
||
|
David E. McConnell
|
||
|
Executive Vice President and Chief Financial Officer
|
||
|
(as a duly authorized officer and principal financial officer)
|
||
|
/s/ David L. Tomlinson
|
||
|
David L. Tomlinson
|
||
|
Senior Vice President - Chief Accounting Officer
|
||
|
(as a duly authorized officer and principal accounting officer)
|
||